Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 6
1981 1
1982 2
1988 1
1989 3
1990 2
1991 7
1992 6
1993 2
1994 6
1995 4
1996 5
1997 2
1999 1
2000 1
2001 5
2003 4
2004 7
2005 7
2006 7
2007 8
2008 8
2009 10
2010 10
2011 8
2012 6
2014 5
2015 5
2016 4
2017 5
2018 2
2019 2
2020 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

145 results
Results by year
Filters applied: . Clear all
Page 1
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.
Pym AS, Diacon AH, Tang SJ, Conradie F, Danilovits M, Chuchottaworn C, Vasilyeva I, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, Van Baelen B, van Heeswijk RP, Dannemann B; TMC207-C209 Study Group. Pym AS, et al. Among authors: andries k. Eur Respir J. 2016 Feb;47(2):564-74. doi: 10.1183/13993003.00724-2015. Epub 2015 Dec 2. Eur Respir J. 2016. PMID: 26647431 Free article. Clinical Trial.
Multidrug-resistant tuberculosis and culture conversion with bedaquiline.
Diacon AH, Pym A, Grobusch MP, de los Rios JM, Gotuzzo E, Vasilyeva I, Leimane V, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, De Paepe E, van Heeswijk RP, Dannemann B; TMC207-C208 Study Group. Diacon AH, et al. Among authors: andries k. N Engl J Med. 2014 Aug 21;371(8):723-32. doi: 10.1056/NEJMoa1313865. N Engl J Med. 2014. PMID: 25140958 Free article. Clinical Trial.
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V. Andries K, et al. Science. 2005 Jan 14;307(5707):223-7. doi: 10.1126/science.1106753. Epub 2004 Dec 9. Science. 2005. PMID: 15591164 Clinical Trial.
Fully weekly antituberculosis regimen: a proof-of-concept study.
Kort F, Fournier Le Ray L, Chauffour A, Jarlier V, Lounis N, Andries K, Aubry A, Guglielmetti L, Veziris N. Kort F, et al. Among authors: andries k. Eur Respir J. 2020 Sep 3;56(3):1902502. doi: 10.1183/13993003.02502-2019. Print 2020 Sep. Eur Respir J. 2020. PMID: 32430417 Free article.
The challenge of new drug discovery for tuberculosis.
Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. Koul A, et al. Among authors: andries k. Nature. 2011 Jan 27;469(7331):483-90. doi: 10.1038/nature09657. Nature. 2011. PMID: 21270886 Review.
Specific HIV-1 reverse transcriptase inhibitors.
Debyser Z, Pauwels R, Andries K, De Clercq E. Debyser Z, et al. Among authors: andries k. J Enzyme Inhib. 1992;6(1):47-53. doi: 10.3109/14756369209041355. J Enzyme Inhib. 1992. PMID: 1285302 Review. No abstract available.
[R207910 (TMC207): a new antibiotic for the treatment of tuberculosis].
Lounis N, Guillemont J, Veziris N, Koul A, Jarlier V, Andries K. Lounis N, et al. Among authors: andries k. Med Mal Infect. 2010 Jul;40(7):383-90. doi: 10.1016/j.medmal.2009.09.007. Epub 2009 Dec 1. Med Mal Infect. 2010. PMID: 19954909 Review. French.
145 results